Kuo FC, Chen CY, Lin NC, Liu C, et al. Optimizing the Safe Washout Period for Liver Transplantation Following Immune
Checkpoint Inhibitors with Atezolizumab, Nivolumab, or Pembrolizumab. Transplant Proc 2023 Apr 29:S0041-1345(23)00232.
PMID: 37127513